Company intelligence / Profile preview

Antibody Systems

Ownership: Private
Development stage: Commercial

Overview

Antibody Systems, Inc. provides diagnostic and therapeutic biological materials—including human serum/plasma samples, rare animal antibodies/proteins—for pharmaceutical R&D worldwide. Their products support development of vaccines, diagnostics, antidotes, blood products, antibiotics from exotic sources like Komodo dragons’ blood/serum. They have decades-long experience with regulatory processes such as IND applications. No direct clinical results since they are not themselves developing drugs.

Therapeutic areas: HematologyCardiovascularInfectious Diseases
Modalities: ProteinAntibodySmall molecule
Industry: Non-Drug Biotech

Partnerships

CDC (Centers for Disease Control & Prevention)Vector Institute (Russia)University of Mexico Medical School in Merida

Beyond the preview

Go deeper on Antibody Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antibody Systems.

Explore the full profile